医药公司 GRAIL, Inc. 盘前直线拉升大涨超20%,三星子公司同意对该公司进行投资,将把GRAIL的癌症早期检测测试引入亚洲。
医药公司 GRAIL, Inc. 盘前直线拉升大涨超20%,三星子公司同意对该公司进行投资,将把GRAIL的癌症早期检测测试引入亚洲。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.